Trifarotene (Aklief) - A New Topical Retinoid for Acne
Date: December 16, 2019
Issue #:
1587Summary:
The FDA has approved trifarotene 0.005% cream
(Aklief– Galderma) for topical treatment of acne
vulgaris in patients ≥9 years old. Trifarotene is the
fourth topical retinoid to be approved in the US for
treatment of acne; tretinoin (Retin-A, and others),
adapalene (Differin, and generics), and tazarotene
(Tazorac, and others) have been available by
prescription for decades. Adapalene 0.1% gel has been
available over the counter since 2016 for treatment of
acne in patients ≥12 years old.
Source: The Medical Letter - Category: Drugs & Pharmacology Authors: admin Tags: Acne Adapalene Aklief Atralin Avita Benzoyl peroxide Biacna Clindamycin Differin Epiduo Retin-A Retinoids Stieva Tactupump Tazarotene Tazorac Tretinoin trifarotene Veltin Ziana Source Type: research